The Patent Finder

Mochida Pharmaceutical Co., Ltd.

78 patents currently held · Updated Nov 16, 2026
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 9 name spellings.

19
Ending by 2030
Dec 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 27, 2026
    The maintenance fee for Anti-presepsin antibody (US 11,685,788) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 1 fee due Jan 28, 2027
    The maintenance fee for Self-emulsifying composition of OMEGA3 fatty acid (US 9,089,483) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
  • 1 fee due Mar 3, 2027
    The maintenance fee for Tetrahydronaphthyl urea derivative (US 10,399,945) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
  • 2 fees due Jun 3 to 22, 2027 · next Jun 3
  • 1 fee due Jul 12, 2027
    The maintenance fee for Composition and/or method for preventing recurrence of stroke (US 9,233,093) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
  • 2 fees due Aug 6 to 27, 2027 · next Aug 6
  • 4 fees due Sep 3 to 29, 2027 · next Sep 3
  • 1 fee due Oct 30, 2027
    The maintenance fee for Alginate Liquid Preparation (US 11,969,437) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,910,751Heterocyclidene acetamide derivative
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,802,718Composition for preventing the occurrence of cardiovascular event in multiple risk patient
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,853,256Composition for preventing the occurrence of cardiovascular event in multiple risk patient
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,700,537Composition for preventing the occurrence of cardiovascular event in multiple risk patient
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,716,775Composition for preventing the occurrence of cardiovascular event in multiple risk patient
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,198,892Composition and/or method for preventing onset and/or recurrence of cardiovascular events
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,233,093Composition and/or method for preventing recurrence of stroke
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,216,201A Method for Regenerating Hyaline Cartilage
In force
 · Medium confidence
In forceMedium confidence
US 10,852,302Method for evaluation of function of phagocyte
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,372,394Compositions and Methods for Treating Cartilage Disease
In force
 · High confidence
In forceHigh confidence
10 of 78 patents shown.
Pro members see all 78.
Pro members: see all 78 patents
Also on record, not counted in the 78: 18 patents in force now held by others · 60 lapsed for an unpaid fee · 93 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

16 pending · 13 abandoned · 47 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited